Stereotaxis to acquire Access Point Technologies

Stereotaxis has struck a deal to buy Access Point Technologies (APT) for an undisclosed sum, to gain robotically steered diagnostic catheter capabilities for its cardiovascular robots. APT is expected to contribute around $5 million in sales in the first year post-acquisition.

“Buying APT 'will significantly amplify and accelerate Stereotaxis' next wave of innovation efforts,' the CEO said.”medtechdive.com

• 1 source
• medtechdive.comStereotaxis inks APT buyout to gain catheters for surgical robots | MedTech DiveNick Paul TaylorMay 16, 2024

Summarized from public sources; check the original articles before acting on it.